1. Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
   Xin Wang et al, 2020, Frontiers in Oncology CrossRef
2. Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities
   Leif Hendrik Dröge et al, 2021, Cancers CrossRef
3. Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX
   Pengqin Xu et al, 2021, Frontiers in Oncology CrossRef
4. Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm, Prospective, Open-Label, Phase II Clinical Trial (TR-EAT)
   Lei Wu et al, 2022, Frontiers in Oncology CrossRef
5. Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis
   Yusuke Sato et al, 2021, Cancers CrossRef
6. Neoadjuvant immunotherapy for resectable esophageal cancer: A review
   Qing Li et al, 2022, Frontiers in Immunology CrossRef